Selected A-share Announcement | Wuliangye Yibin(000858.SZ): Repurchased 1.19 million shares of company stock, with a total transaction amount of approximately 100 million yuan.

Focus Today 1. Wuliangye Yibin: First repurchase of 1.19 million shares, total transaction amount of about 100 million yuan Wuliangye Yibin announced that on May 29, 2026, the company repurchased 1,191,013 shares of the company through a repurchase specific securities account in a centralized competitive bidding manner, accounting for 0.03% of the total share capital of the company. The highest transaction price was 85.25 yuan/share, the lowest transaction price was 82.28 yuan/share, and the total transaction amount was 100 million yuan (excluding transaction costs). As of May 31, 2026, the company has repurchased a total of 1,191,013 shares, with a total payment of 100 million yuan. This repurchase complies with relevant laws and regulations and the company's repurchase plan requirements. 2. Haisco Pharmaceutical Group: To sign a research and development cooperation agreement with Lilly, with a maximum initial payment of 87 million US dollars Haisco Pharmaceutical Group announced that its wholly-owned subsidiary Haisco Pharmaceutical Group Medical Technology (Lhasa) Co., Ltd. signed an "Authorization and Research Cooperation Agreement" with Lilly on May 29, 2026. The two parties will carry out the discovery and early research and development cooperation of up to five innovative drug projects in multiple disease areas. According to the agreement, the company has the right to receive a maximum initial payment and recent payments of 87 million US dollars, as well as a maximum of 2.967 billion US dollars in milestone payments, and has the right to receive tiered sales royalties based on the future net sales of the products. Lilly will have exclusive global rights to the relevant projects, or exclusive global rights outside mainland China, Hong Kong, Macao, and Taiwan, while the company will retain exclusive rights to some projects in mainland China, Hong Kong, Macao, and Taiwan. 3. Chongqing Sokon Industry Group Stock: New energy vehicle sales in May increased by 15% year-on-year, with the listing of the all-new Wenshu M9 exceeding 20,000 orders in 24 hours Chongqing Sokon Industry Group Stock announced that in May, Chongqing Sokon Industry Group Stock's new energy vehicle sales were 33,476 units; the cumulative sales from January to May were 145,108 units, an increase of 15.14% year-on-year. Since the second quarter, the high-end new product Wenshu has continued to be iterated and launched. On May 27, the all-new Wenshu M9 was officially launched, with orders exceeding 20,000 units in 24 hours. 4. Beijing Telesound Electronics: To acquire 51% equity of specialized optical device and module company Zhongke Ruizhe for 251 million yuan Beijing Telesound Electronics announced on May 28, 2026, that the company's stock price had a cumulative deviation value exceeding 20% for three consecutive trading days. The company disclosed its intention to acquire 51% equity of Wuhan Zhongke Ruizhe Optoelectronics Technology Co., Ltd. for 250.92 million yuan in cash on the same day. In addition to this matter, the company, controlling shareholders, and actual controllers do not have any major matters that should be disclosed but have not been disclosed.